Showing results (1-10 of 786) with videos related to

Sort By:
Pageof 79
Trends in Pharmacological Sciences|January 12, 2008
Functional neuroimaging in schizophrenia: diagnosis and drug discoveryPhilip McGuire, Oliver D Howes, James Stone, et al.
Trends in Neurosciences|January 7, 2014
Dopaminergic basis of salience dysregulation in psychosisToby T Winton-Brown, Paolo Fusar-Poli, Mark A Ungless, et al.
Journal of Psychiatry & Neuroscience : JPN|December 8, 2011
Voxel-wise meta-analysis of fMRI studies in patients at clinical high risk for psychosisPaolo Fusar-Poli
Schizophrenia Bulletin|January 6, 2017
The Clinical High-Risk State for Psychosis (CHR-P), Version IIPaolo Fusar-Poli
Current Pharmaceutical Design|January 14, 2012
The vulnerability to schizophrenia mainstream research paradigms and phenomenological directionsGiovanni Stanghellini, Paolo Fusar-Poli
Current Pharmaceutical Design|January 14, 2012
Philosophical issues in the prodromal phase of psychosisMatthew Broome, Paolo Fusar-Poli
BMC Psychiatry|September 14, 2012
White matter pathology--an endophenotype for bipolar disorder?Stefan Borgwardt, Paolo Fusar-Poli
Evidence-Based Mental Health|July 15, 2018
Ten simple rules for conducting umbrella reviewsPaolo Fusar-Poli, Joaquim Radua
Journal of Clinical Psychopharmacology|February 28, 2012
Eicosapentaenoic acid interventions in schizophrenia: meta-analysis of randomized, placebo-controlled studiesPaolo Fusar-Poli, Gregor Berger
Pageof 79